Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desipramine for reduction of methamphetamine craving
IRCT20160813029315N2Phase 3Completed
- Sponsor
- Mental Health Research Center
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of desipramine in methamphetamine use disorder (MUD), sponsored by Mental Health Research Center. Primary endpoint: Change in methamphetamine craving. Started Jun 2016; status: completed.
02
Drugs
desipramine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on IRCT20160813029315N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160813029315N2.